Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    endocrinology

    Familial hypercholesterolaemia

    Also known as: Familial hypercholesterolemia, Inherited hypercholesterolaemia, Heterozygous familial hypercholesterolaemia, Homozygous familial hypercholesterolaemia

    Familial hypercholesterolaemia (FH) is a genetic disorder characterised by lifelong elevation of low-density lipoprotein (LDL) cholesterol, significantly increasing the risk of premature atherosclerotic cardiovascular disease. Clinical management necessitates cascade screening and sustained pharmacological lipid-lowering therapy as central interventions, irrespective of symptomatology. Chinese-medicine assessment may support adjunctive management of associated digestive symptoms, stress, or sleep disturbance; traditional patterns neither diagnose FH nor quantify cardiovascular risk. Current evidence does not establish the efficacy of acupuncture or herbal medicine for FH or cardiovascular event prevention. Reported cohort data demonstrate immune-marker associations rather than proven clinical immunological benefit; other records address glucose regulation, laboratory macrophage studies, and adverse-event reporting. Complementary care must not delay specialist review or substitute for prescribed treatment.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Adhere strictly to prescribed lipid-lowering pharmacotherapy and attend all scheduled specialist or general practice reviews; consult the prescribing physician regarding adverse effects prior to any alteration in dosage.
    • •Consult a dietitian to optimise the substitution of saturated fats with unsaturated fats and enhance dietary fibre intake, acknowledging that nutritional modification is typically insufficient as a monotherapy for inherited LDL elevation.
    • •Maintain regular physical activity consistent with cardiovascular capacity; patients with symptomatic or established cardiovascular disease must obtain medical clearance before initiating strenuous exercise protocols.
    • •Cessation of tobacco use is mandatory; seek clinical cessation support if required and facilitate family cascade screening in coordination with the medical team to identify at-risk relatives.

    Cautions & Contraindications

    See sources
    • •Do not reduce or stop lipid-lowering therapy because symptoms, tongue findings or pulse findings improve. The lifelong LDL exposure and cardiovascular-risk context in [1] is not replaced by traditional pattern assessment; the study does not establish TCM treatment efficacy.[]
    • •Defer elective needling or herbal initiation during unexplained chest pain, focal neurological symptoms or acute breathlessness and arrange urgent assessment. This precaution follows the FH risk context in [1]; it was not evaluated as an acupuncture contraindication in that study.[]
    • •Do not label respiratory symptoms as a confirmed PCSK9 inhibitor reaction or recommend unsupervised withdrawal from reporting signals alone. Coordinate assessment with the prescriber; [4] cannot establish causality, incidence or individual risk.[]

    When to reassess or seek care again

    See sources

    Review adjunctive care after 2–4 weeks using a baseline and follow-up symptom score, sleep diary or stool-frequency record, plus adverse effects and medication adherence. Stop or revise care if there is no meaningful symptom improvement. LDL-C, treatment targets and repeat lipid testing must remain under the medical team's plan; symptom improvement is not a proxy for lipid control. Refer promptly for persistent LDL elevation above the agreed target, suspected medicine intolerance, diagnostic uncertainty or family-screening needs; escalate red flags immediately.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. European heart journal · 2026
    2. World journal of diabetes · 2026
    3. Biomedical reports · 2026
    4. Medicine · 2026

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.